Surgeons, Gastroenterologists and Oncologists) (September 23-26, 2009, Beijing) Fluorouracil intra-arterial infusion combined with systemic gemc

Size: px
Start display at page:

Download "Surgeons, Gastroenterologists and Oncologists) (September 23-26, 2009, Beijing) Fluorouracil intra-arterial infusion combined with systemic gemc"

Transcription

1 1. Results of salvage esophagectomy after definitive chemoradiotherapy in patients with acrcinoma of the esophagus. Watanabe M, Yoshida N, Iwagami S, Toyama E, Hayashi N, Baba H ASCO GI Gastroentestinal Cancers Syposium ( January 15-17, 2009, San Francisco) 2. 5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer -2nd report-. SakamotoY, Takamori H, Tanaka H, Ikuta Y, Nakahara O, Nakagawa S, Furuhashi S, Hashimoto D, Beppu T, Kanemitsu K, Baba H ASCO GI Gastroentestinal Cancers Syposium (January 15-17, 2009,San Francisco) 3. Indicator of cervical lymph node metastasis in thoratic esophageal squamous cell carcinoma. Imamura Y, Hayashi N, Satoh N, Karashima R, Hiyoshi Y, Nagai Y,Yoshida N, Toyama E,Watanabe M, Baba H 4 th Annual Academic Surgical Congress (February 4, 2009, Los Angels) 4. MicroRNA-21 regulates proliferation and invasion in esophagus squamous cell carcinoma. Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y, Hayashi N, Watanabe M, Baba H AACR 100th Annual Meeting 2009 ( April 18, 2009, Denver) 5. Identification of novel tumor-associated antigens, Cadherin3 (CDH3)/P-Cadherin and RAB6KIFL/KIF20A, as targets for anticancer Immunotherapy of pancreatic cancer. Imai K, Baba H AACR 100th Annual Meeting 2009 ( April 18, 2009, Denver) 6. Usefulness of endoscopic ultrasound-guided fine needle aspiration (eus-fna) for digestive organ diseases Nakahara O, Takamori H, Horino K, Tanaka H, Baba H Symposium :Nowadays Achievements in Cancer Diagnosis and Treatment (April 29-May2, Ulaanbaatar) 7. Analysis of the chronic pancreatitis model mice induced the choline-deficient with ethionine (CDE) diet. Ida S, Ohmuraya M, Tanaka H, Horino K, Takamori H, Baba H Symposium :Nowadays Achievements in Cancer Diagnosis and Treatment (April 29-May2, Ulaanbaatar) 8. Differential expression of basement membrane type IV collagen chains as a prognostic factor in extrahepatic bile duct carcinoma. Hirashima K, Iyama K, Baba Y, Sado Y, Ninomiya Y, Takamori H, Baba H 8th Pan-Pacific Connective Tissue Societies Symposium (June 4-7, 2009, Kanagawa) 9. Sequential methotrexate and 5-flouorouracil therapy for gastric cancer patients with bone-marrow metastasis. Iwagami S, Baba H, Iwasaki Y, Hayashi N,Toyama E,Watanabe M, Iwanaga T, Ohashi M 8th International Gastric Cancer Congress ( June 10-13, 2009, Krakow) 10. The clinical significance of the CEA/CA19-9measurement in advanced and recurrent gastric cancer patients. Nagai Y, Watanabe M, Ishikawa S, Imamura Y, Iwagami S, Hayashi N, Takamori H, Baba H 8th International Gastric Cancer Congress (June 10-13, 2009, Krakow) 11. Usefulness of early enteral feeding after total gastrectomy for gastric cancer in patients aged over 80. Watanabe M, Karashima R, Sato N, Hirashima K, Imamura Y, Hiyoshi Y, Nagai Y, Iwagami S, Hayashi N, Baba H 8th International Gastric Cancer Congress (June 10-13, 2009, Krakow) 12. Adenoviral oncolytic suicide gene therapy for peritoneal disseminated model of gastric cancer in mice. Imamura Y, Ishikawa S, Karashima R, Sato N, Hiyoshi Y, Nagai Y, Iwagami S, Hayashi N, Toyama E,Watanabe M, Baba H 8th International Gastric Cancer Congress (June 10-13, 2009, Krakow) 13. Autophagy process activates trypsinogen and the development of acute pancreatitis. Hirota M, Ohmuraya M, Hashimoto D,Yamamura K, Baba H The 41st European Meeting of the European Pancreatic Club (July3, 2009, Szeged) 14. Serine protease inhibitor kazal type 1 promptes proliferation of pancreatic cancer cells through the epidermal growth factor receptor. Ohmuraya M, Hirota M, Ozaki N, Baba H,Yamamura K The 41st European Meeting of the European Pancreatic Club (July3, 2009, Szeged) 15. Liver RFA with Endoscopic Approach. BeppuT, Ishiko T, Baba H 1th Japan korea Image guided Tumor Ablation Meeting (September 12-13, 2009, Tokyo) 16. The clinical significance of VIM expression in gastric cancer cells in bone marrow. Iwatsuki M, Mimori K, Baba H, Mori M 7th International Symposium on Minimal Residual Cancer (September 17, Athens) 17. FOLFOX in combination with hepatic resection and radio-frequency ablation for unresectable colorectal liver metastases. Beppu T, Baba H 19th IASGO (World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (September 23-26, 2009, Beijing) 18. Liver RFA with Endoscopic Approach. Ishiko T, Beppu T, Baba H 19th IASGO World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (September 23-26, 2009, Beijing) 19. Neoadjuvant and adjuvant chemotherapy. Takamori H, Baba H 19th IASGO (World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists) (September 23-26, 2009, Beijing) 20. Laparoscopic surgery for rectal cancer. Hayashi N, Baba H 19th IASGO (World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists) (September 23-26, 2009, Beijing) 21. Delta-shaped anastomosis in totally laparoscopic distal gastrectomy:safe and secure technique for intracorporeal billroth. Ikeda O, Watanabe M, Hayashi N, Baba H 19th IASGO (World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists) (September 23-26, 2009, Beijing) 22. New targeting agents for GI cancerd. Baba H 19th IASGO (World Congress of the International Association of

2 Surgeons, Gastroenterologists and Oncologists) (September 23-26, 2009, Beijing) Fluorouracil intra-arterial infusion combined with systemic gemcitabine for pancreatic cancer. 130 patients. Takamori H, Baba H 40th Anniversary Joint Meeting of the American Pancreatic Association & Japan Pancreas Society (November 3-4, 2009, Honolulu) 24. Laparoscopic surgery and multimodal therapy for hepatocellular carcinoma. Beppu T, Baba H 17th International Postgraduate Course New Frontiers in the Management of Abdominal Diseases (December 4-5, 2009, Athens) 25. Surgery in combination with chemotherapy for unresectable colorectal liver metastases. Beppu T, Baba H 17th International Postgraduate Course New Frontiers in the Management of Abdominal Diseases (December 4-5, 2009, Athens) H2 H3 mfolfox6+bevacizumab) FOLFOX) Kagoshima GI Cancer Forum Kumamoto Clinical Oncology Meeting FU Gemcitabine induction chemotherapy DCF Docetaxel/CDDP/5-FU FOLFOX Current status of SL study in Japan S-1/L FD

3 CEA,CA19-9 CRP oncolytic suicide gene therapy GIST CDCA S-1/LV(1W on 1W off) S-1/L FOLFOX ACHIEVE Symposium FOLFOX HMGA ID1 mrna microrna mcea pre-coagulation hanging manenuer SM MP E-PASS C5a receptor IL-6 microrna

4 Pancreatic intraetpthelial neoplasia(panin) Serine protease inhibitor Kazal type1(spink1) IPMN CT PET-CT FOLFOX FOLFOX FOLFOX CR cm SPARC cancer-associated fibroblast(caf) WISP SBT(spontaneous breathing trial) SSpPD (PpPD)

5 69. TEPP E-PASS scoring system pagetoid spread RAB6KIFL KIF20A myofibroblast Gastrointestinal cancer SPARC GIST cm

6 IVR FOLFOX RFA ICGR15 ICGR15 LHL15, EUS-FNA) E-PASS Estimation of physiologic ability and surgical stress) SPECT CT fusion cm hanging maneuver high volume center Solid-pseudopapillary neoplasm (SPN) Avastin Chugai Implemental Evolution of Expert GIST

7 AFP H3stage S GIST solid-pseudopapillary neoplasm Docetaxel+TS Salvage RAD DCF PDCD GIST - Glivec - 4 GIST up to date SPECT CT-fusion

8 Non-T4 StageII-III DCF (70 )IPMN FOLFOX Salvage pre-coagulation (PSE) E-PASS p12cdk2-ap

9 160. mtor Quality control Wnt/ -catenin HMGA CA C5a C5a (80 ) FDG PET CT HGF, TGF-beta AFP PIVKA-II doubling time STAT SPINK1 EGFR (80 ) E-PASS

10 DCF cstage a DCF pcr SUGT MAP GIST UP to DATE 3 GIST E-PASS E-PASS ocetaxel+ts Oncolytic Suicide Gene Therapy Wnt/ -catenin HMGA E cadherin ZEBI Micro RNA CD microrna, fstage Grade

11 Achieve in NAGANO Pre-coagulation 28 Microwave Surgery UV cut #5, 7, 8a, Docetaxel/Cisplatin/5-FU CR FOLFOX) IPMN Hiroshima Oncology Group of Gastric Cancer (HOG-GC) Liver cell adenoma CDE PDCD SPARC CD cetuximab cn CT PET/CT D

12 228. DCF Salvage SPECT CT-fusion 51 JDDW JDDW JDDW DCF CTL T CD57 NKT PSK PET UP TO DATE GIST CRT DCF p MRI

13 250. PET CT modified DCF Pre-coagulation Hanging maneuver Quality control p SSI (EUS-FNA) cn(+) modified DCF Taxotere S

14 Pre-coagulation Hanging maneuver R EUS-FNA IPMA < (PSE) XELOX XELODA SYMPOSIUM IN OKAYAMA GOF) KSCC ACHIEVE Symposium in Kyushu

15 KSCC Gastroentistinal Oncology Forum GIST

食道がん化学放射線療法後のsalvage手術

食道がん化学放射線療法後のsalvage手術 2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573

More information

ÿþ

ÿþ YV-18 YV-19 YV-20 HALS Surgrx Enseal System 5 29 16:10 17:10 1-1 YP-1 YP-2 YP-3 YP-4 YP-5 YP-6 1 20 TS1 2 5 29 16:10 17:10 1-2 YP-7 YP-8 YP-9 YP-10 YP-11 YP-12 1 IPMN 1 4 3 2 Gemcitabine 5 29 16:10 17:10

More information

CA CA19-9 CA19-9 CA CA CA19-9 ARCHITECT i 2000SR CLIA U/mL CA % CA CA

CA CA19-9 CA19-9 CA CA CA19-9 ARCHITECT i 2000SR CLIA U/mL CA % CA CA 原 著 30 22-29, 2015 CA19-9 CA19-9 CA19-9 2006 12013 6 CA19-9 32,508 37.0U/mL 790 2 CA19-9 320 CA19-9 ARCHITECT i 2000SRCLIA 0.0 37.0U/mL 8 4 1 2 18CA19-9 198.2 46.4 2,968 U/mL 5 3 2.5% CA19-9 2.5% CA19-9

More information

橡

橡 TP T-13i AST ALT ALP Y CTP LOH CHE CRP 8.7 id 0.4 mg/d 21 AWL 131U/L 257 LU/L 12 111/L 234 11J/L 344 IU/L 0.30 mid No K a BUN ORE UA 142 meq/1 4.3 meqa 108 meqa 15.8 met! 0.71 mg/di 5.0 mg/d CEA 5_5 n8/m1

More information

日本消化器外科学会雑誌第30巻第3号

日本消化器外科学会雑誌第30巻第3号 Key words : gastric cancer, progltostic factor. multivariate analysis Factors selected after Coffelation- after Stepwise rnitrally check check H o s t l A g e C O 2 S e x C O 3 Pre-op. compliation O Treatment

More information

1_2.eps

1_2.eps 第32回 日本頭頸部癌学会ランチョンセミナー6 Pre-Meeting Abstract FDG-PET の頭頸部癌における臨床的有用性 司会 長 放射線治療センター長 講演 1 耳鼻咽喉科 部長 講演 2 PETセンター長 岡村 光英 先生 日時 2008年6月13日 金 12:00 13:00 会場 ハイアットリージェンシー東京 共催 第32回 日本頭頸部癌学会 日本メジフィジックス株式会社 136-0075

More information

第79回_プログラム.indd

第79回_プログラム.indd Regulation of ghrelin signaling by a leptin-induced gene, negative regulatory element-binding protein, in the hypothalamic neurons. Phase I clinical trial using peptide vaccine for human vascular endothelial

More information

Unknown

Unknown Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.3 July 2013 Report The 30 th Meeting of Japan Association of Breast and Thyroid Sonology... 1 Department of Organ

More information

業績目録

業績目録 . Kondo, K., Chijiiwa, Y., Otani, K., Kai, M., Ohuchida, J. and Chijiiwa, K.: Characteristics and surgical outcome of HCC patients with low platelet count. Hepato-Gastroenterology, : -,.. : -,.. Fujii,

More information

Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung Carcinoma with Cancerous Pleurisy at Autopsy

Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung Carcinoma with Cancerous Pleurisy at Autopsy Clinicopathological Studies on Cancerous Pleurisy, with Emphasis on Extra-Pulmonary Malignancy Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung

More information

日本消化器外科学会雑誌第29巻第9号

日本消化器外科学会雑誌第29巻第9号 Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe

More information

000-015-v6.ai

000-015-v6.ai Annual Report 2010 http://www.tokyo-jc.or.jp Tokyo JC President AREA Design JAPAN Design TOKYO Design 2010 Year Schedule 2010 Year Schedule 2010 Year Schedule January January February February March March

More information

22肝胆膵_抄録_1_ indd

22肝胆膵_抄録_1_ indd 001 5 26 11:30 12:30 9-1 PO001-1 PO001-2 I II 2cm MRI PO001-3 PO001-4 PO001-5 PO001-6 5cm (Vp3/4,Vv2/3) PO001-7 1 PO001-8 B HCC C HCC B HCC PO001-9 002 5 26 11:30 12:30 9-1 PO002-1 HDAC PO002-2 Down Staging

More information

学位論文の要旨 Combined Analyses of hent1, TS, and DPD Predict Outcomes of Borderline-resectable Pancreatic Cancer (hent1,ts,dpd の組み合わせ検討による切除可能境界膵癌の予後予測 ) Y

学位論文の要旨 Combined Analyses of hent1, TS, and DPD Predict Outcomes of Borderline-resectable Pancreatic Cancer (hent1,ts,dpd の組み合わせ検討による切除可能境界膵癌の予後予測 ) Y 学位論文の要旨 Combined Analyses of hent1, TS, and DPD Predict Outcomes of Borderline-resectable Pancreatic Cancer (hent1,ts,dpd の組み合わせ検討による切除可能境界膵癌の予後予測 ) Yasuhiro Yabushita 藪下泰宏 Department of Gastroenterological

More information

<93C195CA D834F E696E6464>

<93C195CA D834F E696E6464> 45 I I Diabetes and Heart: Insight by Imaging Juhani Knuuti Turku PET Centre, Turku University Central Hospital II I Development and Application of Beta-Amyloid Imaging Agents Chet A. Mathis Department

More information

November 13 June 1 April 23 October 1 December 22 August 6 September 5 July 2 May 2 8 6 11 1 7 01 1516 4 23 4 1995 4 23 1999 4 23 19 2 02 88 5 2 3 03 6 1 6 1 300 4 04 100 7 2 7 2 706 15 2 5 05 8 6 86

More information

Reviews Original Case reports 0.2 0.5 1.0 2.0 0.77 0.64 0.67 0.56 0.81 1.02 1.01 1.14 USA HIP Sweden Malmö Östergötland Kopparberg Stockholm Gothenburg UK Edinburgh Canada NBSS-1 RR=0.82 (0.72-0.95)

More information

MORALITY LEARNING AMBITION 2 KASUMIGAOKA

MORALITY LEARNING AMBITION 2 KASUMIGAOKA KASUMIGAOKA MORALITY LEARNING AMBITION 2 KASUMIGAOKA KASUMIGAOKA 3 4 KASUMIGAOKA KASUMIGAOKA 5 Super Science High School 6 KASUMIGAOKA School Life 4 April 5 May 6 June 7 July 8 August 9 September 10 October

More information

美唄市広報メロディー2014年1月号

美唄市広報メロディー2014年1月号 1 2014 E-mailkouhoujouhou@city.bibai.lg.jp January May September October November December February March June July August April BIBAI CITY INFORMATION http://db.net-bibai.co.jp/bibai/

More information

膵癌超音波診(案)

膵癌超音波診(案) 1 2 3 4 5 6 7 8 9 10 2009 7 6 2 a. invasive ductal carcinoma * 1 b. endocrine neoplasm c. Solid pseudopapillary neoplasm d. tumor producing pancreatitis * 2 * 1 invasive ductal carcinomas papillary adenocarcinoma

More information

92 adenocarcinoma SE ly2 v2 n0 pstage KRAS XX XX 2 1 mfolfox6 l-lv 300 / L-OHP 130 / 5-FU 600 / 5-FU 3,600 / FU/LV de Gramont

92 adenocarcinoma SE ly2 v2 n0 pstage KRAS XX XX 2 1 mfolfox6 l-lv 300 / L-OHP 130 / 5-FU 600 / 5-FU 3,600 / FU/LV de Gramont 92 91 95 2016 5-FU 1 1) 2) 3) 2) 2016 1 5 2016 3 4 FOLFIRI Bevacizumab Bev 5-FU NH3 1 NH 3 5-FU NH 3 Key words: 5-FU : NH 3 orotate phosphorylase OPRT thymidylate synthase TS dihydropyrimidine dehydrogenase

More information

Gynecologic Oncology Trial and Investigation Consortium GOTIC-002

Gynecologic Oncology Trial and Investigation Consortium GOTIC-002 Gynecologic Oncology Trial and Investigation Consortium GOTIC-002 3 8 ...2...2...2...2...3...4...4...5...9...9...9...9...9... 13... 13... 13... 13... 13... 13... 13... 14... 14... 15... 15... 15...

More information

untitled

untitled 24 The 24th Annual Meeting of the Japan Photodynamic Association 10 The 5 th Asian Joint PDT Symposium 2014 6 28 29 24 The 24 th Annual Meeting of the Japan Photodynamic Association 10 The 5 th Asian Joint

More information

1.indd

1.indd 14 15 6 april 6 16 17 18 april 18 april 18 19 28 april 20 21 28 april 22 23 21 may 24 25 10 june 21 may 26 27 10 june 28 29 12 june 30 31 12 25 june 32 33 25 34 35 4 july 37 36 38 39 25 july 25 july 40

More information

MEISEI HEROES HERO HERO HERO MEISEI HEROES

MEISEI HEROES HERO HERO HERO MEISEI HEROES MEISEI HEROES MEISEI HEROES HERO HERO HERO MEISEI HEROES 04 INDEX 06 28 08 24 26 10 14 16 22 18 20 MEISEI HEROES 05 04 MEISEI HEROES 2014 SCHOOL GUIDE MEISEI HEROES 1 2 3 4 5 06 MEISEI HEROES 2014 SCHOOL

More information

untitled

untitled 19 CSPOR CRC/2009.8.8-9 2009 8 8 ( ) - CSPOR CRC SEMINAR- twatanab@oncoloplan.com http://www.oncoloplan.com - Toru Watanabe MD - 2 Phase I: Dose Finding trial Phase II : Efficacy and Safety trial Phase

More information

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ 29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27

More information

untitled

untitled 260 250 200 150 10 100 50 0 1960 1965 1970 1975 1980 1985 1985 1995 2000 2005 25% 56% 66% 60% 90 80 70 60 50 40 30 20 10 0 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 1999 1990 2003 2005 2010 500,000 70,000 100,000

More information

<2003年分東京医科歯科大学産科婦人科学教室業績>

<2003年分東京医科歯科大学産科婦人科学教室業績> 1.Obayashi S, Aso T, Sato J, Hamasaki H, Azuma H: Intimal hyperplasia in human uterine arteries accompanied by impaired synergism between prostaglandin I2 and nitric oxide. British Journal of Pharmacology

More information

I

I I. 学会発表 A. 国内学会および研究会 1) 2) 3) 4) 5) 6) 7) 8) 9) 10) 11) 12) 13) 14) 15) 16) 17) 18) 19) 20) 21) 22) 23) 24) 25) 26) 27) 28) 29) 30) 31) 32) 33) 34) 35) 36) 37) 38) 日本食道学会日本医学会総会日本医学放射線学会日本胃癌学会日本化学療法学会日本核医学会日本画像医学会日本癌学会日本癌治療学会日本気管食道科学会日本胸部外科学会日本形成外科学会日本外科学会日本外科感染症学会日本外科系連合学会日本サイコオンコロジー学会日本再生医療学会日本磁気共鳴医学会日本自己血輸血学会日本消化管学会日本消化器がん検診学会日本消化器癌発生学会日本消化器外科学会日本消化器内視鏡学会日本消化器内視鏡学会地方会日本消化器病学会日本小児外科学会日本組織培養学会日本超音波医学会日本頭頸部癌学会日本頭頸部外科学会日本内科学会日本内視鏡外科学会日本ハイパーサーミア学会日本ヒト細胞学会日本病理学会日本腹部救急医学会日本放射線腫瘍学会

More information

untitled

untitled ( ) - 1 - - 2 - 38% 26% A) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma 124 (J Clin Oncol 7: 126-131, 1989) 124 95 29 II 1 2,000mg/m 2 x 4 8g/m

More information

*4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combinati

*4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combinati *4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combination with angiotensin II induced hyperten sion chemotherapy

More information

慢性膵炎

慢性膵炎 - - 121 , g CCK g g - kgkcal kgkcal - g,,, - G.I.Res ; 10 : - ; 13 : - ; 22 : - Meier RF, Beglinger C. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol ; 20 : - Pfutzer RH, Schneider

More information

NL16-1_0329

NL16-1_0329 No.16-1 March. 2012 JAMTTC News Letter http://jamttc.umin.jp/ Japanese Association for Molecular Target Therapy of Cancer 135-85503-8-31 TEL: 03-3520-0111 ext.5413 FAX: 03-3570-0484 ...1 JAMTTC2012...2...3...4...5

More information

Unknown

Unknown Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.3, No.3 July 2014 Original Article Clinical significance of classification of mixed-pattern tumor by breast ultrasound...

More information

1 May 2011

1 May 2011 1 May 2011 2 May 2011 3 May 2011 4 May 2011 5 June 2011 6 June 2011 7 June 2011 8 June 2011 9 July 2011 10 July 2011 11 July 2011 12 July 2011 13 August 2011 14 August 2011 15 August 2011 16 August 2011

More information

VOL.48 NO.5 Key words: locally advanced esophageal cancer, multimodality therapy, neo- adjuvant chemoradiotherapy

VOL.48 NO.5 Key words: locally advanced esophageal cancer, multimodality therapy, neo- adjuvant chemoradiotherapy VOL.48 NO.5 Key words: locally advanced esophageal cancer, multimodality therapy, neo- adjuvant chemoradiotherapy MAY 2000 VOL.48 NO.5 MAY 2000 Table 2. Adverse events Toxicity was defined according to

More information

日本消化器外科学会雑誌第23巻第2号

日本消化器外科学会雑誌第23巻第2号 Key words: carcinoma of the pancreatic head, carcinoma of the periampullary region, operative results of the pancreatic duodenal carcinoma, mode of tumor spread of the pancreatic duodenal carcinoma, factors

More information

様式 6( 第 15 条第 1 項関係 )( 採択年度 = 平成 26 年度以降 ) 平成 28 年 4 月 8 日独立行政法人研究機関の設置者の 日本学術振興会理事長殿所在地熊本市中央区黒髪 2 丁目 39 番 1 号研究機関の設置者の国立大学法人熊本大学名称 代表者の職名 氏名

様式 6( 第 15 条第 1 項関係 )( 採択年度 = 平成 26 年度以降 ) 平成 28 年 4 月 8 日独立行政法人研究機関の設置者の 日本学術振興会理事長殿所在地熊本市中央区黒髪 2 丁目 39 番 1 号研究機関の設置者の国立大学法人熊本大学名称 代表者の職名 氏名 様式 6( 第 15 条第 1 項関係 )( 採択年度 = 平成 26 年度以降 ) 平成 28 年 4 月 8 日独立行政法人研究機関の設置者の 860-8555 日本学術振興会理事長殿所在地熊本市中央区黒髪 2 丁目 39 番 1 号研究機関の設置者の国立大学法人熊本大学名称 代表者の職名 氏名学長 原田信志 ( 記名押印 ) 代表研究機関名 熊本大学 17401 及び機関コード 平成 27 年度戦略的国際研究交流推進事業費補助金実績報告書

More information

TAIHO_E&S

TAIHO_E&S 2006 Environmental and Social Report INDEX 2 3 5 6 7 9 11 12 13 14 15 17 18 19 21 23 25 26 27 28 29 30 1 TAIHO Environmental and Social Report 2006 2 3 TAIHO Environmental and Social Report 2006 Company

More information

Group5 tub1 CT ct4b cn1 ch0 cp0 cm0 cstage a D3 A V Type5 muc tub1 pt4b pn1 1/28 No. 201 pstage a UFT/UZEL 5

Group5 tub1 CT ct4b cn1 ch0 cp0 cm0 cstage a D3 A V Type5 muc tub1 pt4b pn1 1/28 No. 201 pstage a UFT/UZEL 5 91 113 117 2015 1 2015 2 4 2015 2 23 73 3 Group5 tub1 CT ct4b cn1 ch0 cp0 cm0 cstage a D3 A V Type5 muc tub1 pt4b pn1 1/28 No. 201 pstage a UFT/UZEL 5 22 Key words: Ⅰ 0.2 1 0.01 2 1 D3 1 Ⅱ 73 2012 12 Takeshi

More information

研究成果報告書

研究成果報告書 21 5 28 2007 2008 CARElk CARPXR CAR CAR EST cdna CAR CAR 10FCS 96 SW480 HepG2 anti-lamin A/C anti-phospho-histone H3 anti-cyclin D1 G1 anti-cyclin A S CAR lamin A/C CAR Fig. 1 Lamin A/C /G1 lamin A/C G1

More information

Treatment Architecture 2018 Japan / United States / Western Europe

Treatment Architecture 2018 Japan / United States / Western Europe Treatment Architecture 2018 Japan / United States / Western Europe 12 月発刊レポートのご案内 Treatment Architecture 2018 12 月発刊レポートの一覧 12 月は下記の 5 がん種のレポートを発刊しております 最新の調査結果をご活用ください 最新の調査では昨年までの調査項目を引き継ぎつつ 新しい作用機序の薬剤

More information

02-Preface†i5†j

02-Preface†i5†j Past, Present, and Future of Radiation Oncology Masahiro Hiraoka, M.D. Department of Therapeutic Radiology and Oncology, Kyoto University Graduate School of Medicine NICHIDOKU-IHO Vol. 50 No. 1 98 104

More information

Powered by TCPDF (www.tcpdf.org) Title 食道癌治療のパラダイムシフト Sub Title Paradigm shift in treatment for esophageal cancer Author 安藤, 暢敏 (Ando, Nobutoshi) Publisher 慶應医学会 Publication year 2005 Jtitle 慶應医学 (Journal

More information

ANALYSIS OF RADIOTHERAPY FOR LUMBOSACRAL CARCINOMATOUS NEUROPATHY Masatoshi TANIGUCHI, Yuko KANEYASU, Kumiko KARASAWA, Noboru FUKUHARA Makiko TANAKA,

ANALYSIS OF RADIOTHERAPY FOR LUMBOSACRAL CARCINOMATOUS NEUROPATHY Masatoshi TANIGUCHI, Yuko KANEYASU, Kumiko KARASAWA, Noboru FUKUHARA Makiko TANAKA, ANALYSIS OF RADIOTHERAPY FOR LUMBOSACRAL CARCINOMATOUS NEUROPATHY Masatoshi TANIGUCHI, Yuko KANEYASU, Kumiko KARASAWA, Noboru FUKUHARA Makiko TANAKA, Midori KITA-Okawa, Tomohiko OKAWA (Received 8 December

More information

研究成果報告書(基金分)

研究成果報告書(基金分) (1) 種類 程度 肥満細胞数の測定と組織でのサ RT-PCR FACS () (1) NMU-/- IgE NMU IgE -/-NMU -/-B IgE NMU -/-B6 IgE NMU NMU CTLMC BMMC IgE NMU CTLMC 13 1. Hayakawa J, Mizukawa Y, Kurata M, Shiohara T: A syringotropic variant

More information

がん診療におけるFDG FDG-PET/CTの役割

がん診療におけるFDG FDG-PET/CTの役割 PET/CT PET/CT MRI PET PET/CT Kurashiki Central Hospital FDG-PET CT PET/CT (stage1) FDG-PET (stage1) PET/CT FDG-PET PET/CT (stage4) FDG-PET (stage4) PET/CT FDG-PET PET/CT PET/CT

More information

Fine needle aspiration cytology in gynecologic malignancy Nao KINO1), M. D., Masaki FUJIMURA1), M. D., M. I. A. C., Takako SHIRAI1), M. D., M. I. A. C

Fine needle aspiration cytology in gynecologic malignancy Nao KINO1), M. D., Masaki FUJIMURA1), M. D., M. I. A. C., Takako SHIRAI1), M. D., M. I. A. C Fine needle aspiration cytology in gynecologic malignancy Nao KINO1), M. D., Masaki FUJIMURA1), M. D., M. I. A. C., Takako SHIRAI1), M. D., M. I. A. C., Michiko TAKAHASHI1), M. D., M. I. A. C., Katsutoshi

More information

Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.1 January 2013 Overview History of JABTSJapan Association of Breast and Thyroid Sonology : Dawn of a JABTS Age; The

More information

2011上宮太子_高校_学校案内

2011上宮太子_高校_学校案内 UENOMIYA TAISHI SENIOR HIGH SCHOOL GUIDE BOOK 2011 www.uenomiya-taishi.ed.jp Curriculum Curriculum Letʼs enjoy school life at UT! 01 02 4 April 5 May 6 June 7 July 03 8 9 10 11 August September October

More information

SOZO_経営_PDF用.indd

SOZO_経営_PDF用.indd Faculty of Business Administration Department of Business Administration CONTENTS ADMISSION POLICY 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 INTERNET SOZO Wireless Network 16 Campus Life Calendar APRIL MAY JUNE

More information

untitled

untitled 1) American College of Surgeons:Advanced Trauma Life Support Course Manual. American College of Surgeons 1997;103-112 24 2) American Society of Anesthesiologists Task Force:Practice guideline for blood

More information

Title 骨量規定転写因子シュニュリ3の新規標的遺伝子同定と機能解析 Author(s) 石堂, 康弘 Citation Issue Date 2014-06-27 URL http://hdl.handle.net/10232/24125 http://ir.kagoshima-u.ac.jp adult (Schnurri, Shn)3/Hivep3 Runx2 Shn/Hivep Shn3

More information

VOL. 21 NO. 2 CHEMOTHERAPY 395

VOL. 21 NO. 2 CHEMOTHERAPY 395 394 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 395 396 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 397 398 CHEMOTHERAPY MAR. 1973 VOL. 2 1 NO. 2 CHEMOTHERAPY 399 400 CHEMOTHERAPY MAR. 1973

More information

VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3

VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3 VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3 2 OptiView ALK D5F3 11 10 79.3%31% 18% 80 85NSCLC 40% 1,2 1 1018 ALK ALK 2 ALK 3 5% ALK EML4 EML4-ALK Coild-Coil ALK ALK 3,4,5 2 6 EGFR 50%

More information

研究成果報告書

研究成果報告書 系 レニン 1. Ito D, Ito O, Mori N, Suda C, Hao K, Cao P, Muroya Y, Takashima K, Shimokawa H, Kohzuki M. Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.

More information

業績集2011.8より.xlsx

業績集2011.8より.xlsx 2011.4-2012.3 2011 4 pp.80-86 2011 4 pp.100-106 2011 4 pp.171-185 2011 7 pp26-29 2011 8 2011 8 pp56-61 2011 11 pp117-127 2011 11 pp.245-252 2011 11 2011 12 1 12 13 Osawa Y,Oguma Y Effects of whole-body

More information

Special IssueTo save our life from myocardial infarction -what can we do before and after heart attack- Reviews Originals Case reports et al et al et al et al et al et al et al et al et al et al et

More information

核44-4 (ガイドライン)-1

核44-4 (ガイドライン)-1 FDG-PET (2007) PET FDG PET * 2 * PET FDG PET PET/CT PET PET PET PET PET PET PET CT PET QOL PET PET PET PET 2 1. 2. 3. 4. 5. 6. 7. 8. 9. 9-1) 9-2) 9-3) FDG-PET 9-4) 9-5) A. CT B. PET/CT 9-6) MRI 9-7) 10.

More information

Rinku General Medical Center

Rinku General Medical Center Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines

More information

084_41-1_23四国CS6_念*.indd

084_41-1_23四国CS6_念*.indd 2013 10 5 The forgotten chamber.,,,.1.2,,, 3,,. 4,CT,MRI,,,,,,,, fractional area change: FAC,,M tricuspid annular plane systolic excursion: TAPSE TAPSE < 16 mm., s, speckle tracking, Tei index,,,.,,,.,6,.,,,,,

More information

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案) VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.

More information

日本消化器外科学会教育集会

日本消化器外科学会教育集会 Medical oncology T4N4M1 I 1T4 T4 T4 T4 1 T4 down-staging T4 40Gy 1 2820 R0 down-staging R0 2 T440Gy 20Gy 3 T460Gy 4 T4 down-staging T4 43 5 1511 R0 T4 1 T436Gy 6 30 18 R0 T4 1 11 3 R0 Salvage T4 Lerut

More information

GOVERNOR'S No.1 JULY 2 GOVERNOR'S No.1 JULY 3 GOVERNOR'S No.1 JULY 4 GOVERNOR'S No.1 JULY 5 GOVERNOR'S No.1 JULY 6 GOVERNOR'S No.1 JULY 7 GOVERNOR'S No.1 JULY 8 GOVERNOR'S No.1 JULY 9 GOVERNOR'S No.1 JULY

More information

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 ポスターについて 1. ポスター 貼 付 用 の 展 示 ボードは 縦 180 横 90cm の 大 きさです 2. 演 題 名 発 表 者 名 所 属 を 明 記 したもの(20 70cm) をご 用 意 ください 実 際 使 用 できるスペースは 155

More information

!

! The 22nd Annual Meeting of the Japanese Association of Cardiac Rehabilitation ! The 22nd Annual Meeting of the Japanese Association of Cardiac Rehabilitation The 22nd Annual Meeting of the Japanese Association

More information

後ろ.indd

後ろ.indd 2010 p.1-42 2010 7 The relation between food intake of pregnant women and fetal growth -case sutudy- Vol.11 No.3 p.481-4862010 11 The 10th Hamamatsu-kyungpook Joint Medical Symposium, p.54, School of Medicine,Kyugpook

More information

untitled

untitled 1988 2000 2002 2004 2006 2008 IFN Lamivudine Adefovir Entecavir 1 Total number 560 Sex (male/female) 424/136 Age (years)* 38 (15-68) Duration of treatment (weeks)* 26 (1-592) Follow-up time (years) 75(05-21

More information

1) Kojima H: Culture of ejaculate for Neisseria gonorrhoeae, 1st Serually Transmitted Diseases World Congress, San Juan, 11. 19, 1981. 9) Kojima H, Mori C: Clinical studies on Conococcal and Chlamydial

More information

研究成果報告書

研究成果報告書 様式 C-19 科学研究費助成事業 ( 科学研究費補助金 ) 研究成果報告書 平成 24 年 5 月 15 日現在 機関番号 :84409 研究種目 : 基盤研究 (C) 研究期間 :2009 ~2011 課題番号 :21590412 研究課題名 ( 和文 ) 転写因子 ELF2 の機能解析と予後因子としての有用性の検討 研究課題名 ( 英文 )Functional analysis of transcription

More information

5 I The Current Situation and Future Prospects of the North Korean Economy presented at the 2014 Korea Dialogue Conference on Strengthenin

5 I The Current Situation and Future Prospects of the North Korean Economy presented at the 2014 Korea Dialogue Conference on Strengthenin 5 I. 3 1 1990 2 The Current Situation and Future Prospects of the North Korean Economy presented at the 2014 Korea Dialogue Conference on Strengthening North Pacific Cooperation organized by the East-West

More information

Ⅱ Hb 4.1g/dl S LST G S ESD 10 S S 4 4 S D mL tub1 muc SS ly0 v0 PM0 DM0 N0 0/27 S tub1 tub2 SS

Ⅱ Hb 4.1g/dl S LST G S ESD 10 S S 4 4 S D mL tub1 muc SS ly0 v0 PM0 DM0 N0 0/27 S tub1 tub2 SS 92 183 188 2016 1 1,2) 1) 1) 1) 1) 1) 3) 1) 2016 2 1 2016 3 11 84 S 2011 10 S 30 40 2 tub1 muc SS ly0 v0 PM0 DM0 N0 0/27 S 30 30 2 tub1 tub2 SS ly0 v0 PM0 DM0 N0 0/19 stage tub1 M ly0 v0 HM0 VM0 stage

More information

- 1 -

- 1 - - 1 - 35:261-262 2005.12 35:153-154 2005.12-2 - 15500383 15-17 2006.3 [] 1 17(5):161-165 2005.5 32(3):130-134 2005.6 Synovial fringe 1 22(3):322 2005.10 Pancoast 56(13):1663-1666 2005.12 [] 22(5):788-795

More information

Microsoft Word - 2012 年度業績word _1_.docx

Microsoft Word - 2012 年度業績word _1_.docx 2012 年 度 論 文 総 説 解 説 1. 岩 間 毅 夫, V. 消 化 器 ( 管 ) ポリポーシス 1. 遺 伝 性 大 腸 癌 症 候 群. 内 科 109:1198.1201,2012 2. 熊 谷 洋 一, 戸 井 雅 和, 石 畝 亨, 川 田 研 郞, 石 田 秀 行, 河 野 辰 幸. 血 管 新 生 の 見 地 からみた 食 道 癌 の 発 育 進 展. 胃 と 腸 47:1428.1434,2012

More information

_02戸沢.indd

_02戸沢.indd Akita J Med 43 : 79-86, 2016 15 1 1 1 1 2 2 3 4 4 1 2 3 4 received 19 July 2016, accepted 29 July 2016 Two cases of histological CR for squamous cell lung cancer with invasion to the pulmonary artery after

More information

3 6 6 8 5 5 0 4 3 4 4 0,000 3 ID ID ID 4 7 9 :5 4 5 60-8048 NACOS TEL: 075-45-366 FAX: 075-45-366 E-mail: jiao@nacos.com 3. Power Point PC 0 5. Power Point PC 7 3 3. 3 5 PC PC PC Windows Power Point USB

More information

スライド 1

スライド 1 QOL 1 Goldberg, JCO 22:23-30, 2004 N9741: Oxaliplatin in First Line (US) IR 200 mg/m 2 OX 85 mg/m 2 every 3 weeks Efficacy IFL FOLFOX4 > IFL IROX FOLFOX4 IROX OS TTP RR 15.0 mo 6.9 mo 31 % P=0.0001 P=0.0014

More information

01.浅野.ppt

01.浅野.ppt 2010 14 23 1 15 2010 the 74 th Annual Scientific Meeting of American College of Rheumatology November 7 11, 2010 at Georgia World Congress Center, Atlanta, GA, USA 2284 SSc 142 Plenary Session: 3 Concurrent

More information

PROGNOSTIC FACTORS OF LATERAL WALL OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TOMOHIKO NIGAURI, M.D., SHIN ETSU KAMATA, M.D., KAZUYOSHI KAWABATA, M.D. MUNE

PROGNOSTIC FACTORS OF LATERAL WALL OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TOMOHIKO NIGAURI, M.D., SHIN ETSU KAMATA, M.D., KAZUYOSHI KAWABATA, M.D. MUNE PROGNOSTIC FACTORS OF LATERAL WALL OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TOMOHIKO NIGAURI, M.D., SHIN ETSU KAMATA, M.D., KAZUYOSHI KAWABATA, M.D. MUNENAGA NAKAMIZO, M.D., KATSUFUMI HOKI, M.D., HIROKI MITANI,

More information

Table 1 Laboratory findings on admission Figure 2. Clinical course after admission 1-a 1-b 1-c 3-a 3-b 3-c Figure 1. CT findings on first admission: S

Table 1 Laboratory findings on admission Figure 2. Clinical course after admission 1-a 1-b 1-c 3-a 3-b 3-c Figure 1. CT findings on first admission: S FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF Vol. 32, pp. 105 110, 2004 FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF 1 1 1 1 1 1 1 1 2 2 1 1 16 4 13 72 CRP

More information

Ann. Phytopath. Soc. Japan 53 (3). July, 1987 369

Ann. Phytopath. Soc. Japan 53 (3). July, 1987 369 Abstracts of Papers Presented at the Annual Meeting of the Society, Tokyo, March 30-April 1, 1987 Ann. Phytopath. Soc. Japan 53 (3). July, 1987 369 Ann. Phytopath. Soc. Japan 53 (3). July, 1987 371 Ann.

More information

02-06プ_一般ポスター_0407.indd

02-06プ_一般ポスター_0407.indd 一般ポスター工学基礎一般ポスター工学基礎 イメージング 信号処理 5 月 7 日 ( 土 )6:0-7:0 ポスター 展示会場 座長 : ( 栃木県総合文化センター 階第 4 ギャラリー ) 90- 基 P-00 CT S6 90- 基 P-00 S6 90- 基 P-00 S6 90- 基 P-004 S6 90- 基 P-005 S64 90- 基 P-006 S64 90- 基 P-007 STC

More information

44-1(前11)7回春季大会

44-1(前11)7回春季大会 PET 5 18 5 20 5 18 5 20 5 18 5 20 5 18 5 20 5 18 17:10 18:35 19 5 18 20 URL: http://www.t-inform.co.jp/jsnm-s7/ 7 http://www.t-inform.co.jp/jsnm-s7/ 7 19 5 18 20 7 7 PET PET PET RI 2 19 PET PET PET 1

More information

1. Sugimura, T. and Fujimura, S.: Tumor production in glandular stomach of rat by N-methyl-N'-nitro- N-nitrosoguanidine. Nature, 216, 943-944, 1967. 2. Fujimura, S., Kogure, K., Sugimura, T. and Takayama,

More information

F A 1 13:00 14:00 O StageIV O O O O O ESD ,2, ,2 1,2 1,

F A 1 13:00 14:00 O StageIV O O O O O ESD ,2, ,2 1,2 1, 11 1 1 11 1 11 1 1 1 2F A 1 13:00 14:00 O1-1 80 StageIV 7 5 2 O1-2 7 5 2 O1-3 857 5 2 O1-4 7 5 2 O1-5 857 5 2 O1-6 85 ESD 7 5 2 1,2,3 3 3 3 1,2 1,2 1,2 1 1 1 1 2 3 O1-7 90 7 5 2 O1-8 7 5 2 1 1 1 1 2 3

More information

口腔癌の早期発見のために For the early detection of oral cancer Kazumasa Sugihara Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and M

口腔癌の早期発見のために For the early detection of oral cancer Kazumasa Sugihara Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and M Title 口腔癌の早期発見のために Author(s) 杉原, 一正 Citation 鹿児島大学歯学部紀要, 34: 3-11 Issue Date 2014 URL http://hdl.handle.net/10232/20682 http://ir.kagoshima-u.ac.jp 口腔癌の早期発見のために For the early detection of oral cancer Kazumasa

More information

肝 細 胞 癌 に 対 する 肝 切 除 前 neoadjuvant chemotherapy の 検 討 第 38 回 リザーバー 研 究 会 ( 高 松 市 ) 2013/6/28 切 除 不 能 大 腸 癌 肝 転 移 症 例 に 対 する 肝 動 注 化 学 療 法 の 検 討 第 38 回

肝 細 胞 癌 に 対 する 肝 切 除 前 neoadjuvant chemotherapy の 検 討 第 38 回 リザーバー 研 究 会 ( 高 松 市 ) 2013/6/28 切 除 不 能 大 腸 癌 肝 転 移 症 例 に 対 する 肝 動 注 化 学 療 法 の 検 討 第 38 回 2013 年 度 < 消 化 器 内 科 > 乏 血 性 高 分 化 型 肝 細 胞 癌 における 造 影 超 音 波 所 見 と 動 注 CT EOB-MRI との 比 較 検 討 第 86 回 日 本 超 音 波 学 会 ( 大 阪 市 ) 2013/5/24-25 予 後 延 長 のための 進 行 肝 細 胞 癌 に 対 する 肝 動 注 化 学 療 法 第 49 回 日 本 肝 臓 学 会

More information

NCDデータを用いた全国消化器外科領域内視鏡手術の現況に関する調査結果(速報)

NCDデータを用いた全国消化器外科領域内視鏡手術の現況に関する調査結果(速報) 2014.12 NCD データを用いた全国消化器外 科領域腹腔鏡手術の現況に関する 緊急調査結果 ( 速報 ) 日本外科学会 日本消化器外科学会 Na&onal Clinical Database 1 目的 腹腔鏡手術を受けた患者が合併症などにより残念な結果となったという昨今の報道を受け わが国の腹腔鏡消化器外科手術の症例数の現状と安全性を緊急調査する 2 方法 2011-2013 年の 3 年間に

More information

untitled

untitled 21 The 21 st Annual Meeting of ENDOSCOPIC SURGERY FORUM in TOHOKU FUKUSHIMA 2010 417 The 21 st Annual Meeting of ENDOSCOPIC SURGERY FORUM in TOHOKU 21 2010 417 TEL024-547-1259FAX024-548-3249 E-mail: esf21@fmu.ac.jp

More information

50-3ガイド10ポ.indd

50-3ガイド10ポ.indd 25 7 乳房専用 PET 診療ガイドライン作成メンバー PET 1 はじめに PET 18 F-2- -2- -D- FDG 14 12 FDG-PET FDG-PET 1) T1b 0.5 cm 1.0 cm T1c 1.0 cm 2.0 cm P=0.003 1.0 cm 2) MRI FDG-PET PET 1 cm FDG FDG 1 対向型乳房専用 PET 装置 2 2 3 6) 2 4

More information

好酸球性副鼻腔炎:診断ガイドライン(JESREC Study)

好酸球性副鼻腔炎:診断ガイドライン(JESREC Study) 118 728 2015 : : JESREC Study Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis Study : JESREC Study CT NSAIDs CT : JESREC Study JESREC Study 118 729 ph CTMRI Caldwell Luc

More information

11 第25回がん学会一般演題一覧(第3会場)

11 第25回がん学会一般演題一覧(第3会場) 1) 2) 1) 2) KTSND 2 200 KTSND KTSND 2014 4 CD56 Chromogranin Ki67 70% CT T2N4M0stage IVa /(egfr 55ml/min Cre 1.05mg/dl)/ PR 12 2015 4 CT 6 62 20XX 6 CTMRI 5 7 10 DIC methotrexatemtx /5-FU DIC score ALP

More information

2 2. 13 2 1 1 PBS: Post-Boost Stage 1.2 2 30 JAXA 49 2 108 4 205

2 2. 13 2 1 1 PBS: Post-Boost Stage 1.2 2 30 JAXA 49 2 108 4 205 252 5210 3 1 1 e-mail: morita.yasuhiro@jaxa.jp 9 1. 1 F1 1 204 2015 4 2 2. 13 2 1 1 PBS: Post-Boost Stage 1.2 2 30 JAXA 49 2 108 4 205 IT IT 3 2 JAXA 2 3 1 2 2 2 3 2 206 2015 4 C/C 2 3. 3.1 1 SRB-A H2A

More information